In addition to EGFR mutations, KRAS gene mutations, which are responsible for NSCLC in 30% of white patients and 10%–15% of Asian patients, are also a prognostic factor [12, 31]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.